CROI 2015 Program and Abstracts

General Information

COMMERCIAL SUPPORT

General Information

The Conference on Retroviruses and Opportunistic Infections (CROI) is largely supported by the registration fees of participants. In addition, the organizers seek grants from commercial companies, particularly from companies with competing products. These companies have no input in or control over the selection of faculty or content of the presentations. CROI 2015 has, to date, received grant support commitments from the following commercial companies:

Platinum Gilead Sciences, Inc

Merck & Co, Inc ViiV Healthcare

Gold Bristol-Myers Squibb Janssen Therapeutics, Division of Janssen Products, LP

Silver AbbVie

Additional support has been provided by Mylan, Inc

vi

CROI 2015